Can Accutane (isotretinoin) cause hair loss in a young adult or adolescent with severe acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Accutane Cause Hair Loss?

Yes, Accutane (isotretinoin) can cause hair loss, but it occurs in a minority of patients and is typically reversible. According to the American Academy of Dermatology guidelines, alopecia is listed as a recognized adverse effect of isotretinoin, though frank alopecia (severe hair loss) occurs in less than 10% of treated patients 1.

Understanding the Risk and Pattern

Hair loss from isotretinoin typically presents as telogen effluvium, a diffuse, non-scarring pattern where hair follicles are pushed prematurely into the resting phase 2. This type of hair loss:

  • Usually begins 1-3 months after starting the medication 2
  • Manifests as diffuse shedding across the scalp rather than patchy loss 2
  • Is reversible upon drug withdrawal or dose adjustment 2
  • Resolves within 3-6 months as the body adjusts, with hair regrowing at approximately 1 cm per month 2

Incidence and Risk Factors

The actual incidence of hair loss with isotretinoin is relatively low compared to other retinoids. Isotretinoin demonstrates "less hair loss" compared to acitretin, another retinoid that causes alopecia in up to 75% of patients 1, 2.

A retrospective study of 6,330 patients found that among those who experienced hair loss, certain factors were associated with increased risk 3:

  • Older age at time of treatment 3
  • Higher cumulative doses of isotretinoin 3
  • Longer duration of treatment 3

In a prospective study following 124 treatment courses, hair loss was experienced in a small percentage of patients and was rarely noted on more than one occasion, suggesting it may be transient even during continued treatment 4.

Clinical Significance and Management

For most patients, the risk of hair loss should not deter isotretinoin use when indicated for severe or treatment-resistant acne. The American Academy of Dermatology guidelines emphasize that patients with psychosocial burden or scarring should be considered candidates for isotretinoin 1.

Management approach when hair loss occurs:

  • Consider dose reduction rather than complete discontinuation if acne control is adequate 2
  • Reassure patients that hair loss is typically reversible 2
  • Monitor for resolution within 3-6 months after dose adjustment or discontinuation 2
  • Continue treatment if hair loss is mild and cosmetically acceptable, as the benefit for severe acne often outweighs this side effect 1

Important Caveats

Do not confuse isotretinoin-induced hair loss with other conditions. One study documented a case of alopecia areata developing during isotretinoin treatment, which represents a different pattern (localized patches rather than diffuse thinning) 5. Additionally, a short-term study using TrichoScan analysis found no statistically significant changes in hair growth parameters after 3 months of treatment at 0.5 mg/kg per day, suggesting that at standard doses and shorter durations, measurable effects on hair cycling may be minimal 6.

The exact mechanism by which isotretinoin causes hair loss remains unclear, though it is thought to relate to the drug's effects on hair follicle cycling 3, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anticoagulant-Associated Hair Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Isotretinoin use in acne: prospective evaluation of adverse events.

Journal of cutaneous medicine and surgery, 2000

Research

Effects of isotretinoin on the hair cycle.

Journal of cosmetic dermatology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.